Busey Wealth Management Eli Lilly & CO Transaction History

Busey Wealth Management

$3 Billion
Q3 2024

A detailed history of Busey Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Busey Wealth Management holds 23,331 shares of LLY stock, worth $18.4 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

23,331

Previous 23,062 1.17%

Holding current value

$18.4 Million

Previous $20.9 Million 1.01%

% of portfolio

0.69%

Previous 0.73%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$772.14 - $960.02 $207,705 - $258,245	269 Added 1.17%	23,331 $20.7 Million
Q2 2024 Jul 23, 2024	SELL	$724.87 - $909.04 $297,921 - $373,615	-411 Reduced 1.75%	23,062 $20.9 Million
Q1 2024 Apr 23, 2024	BUY	$592.2 - $792.28 $120,216 - $160,832	203 Added 0.87%	23,473 $18.3 Million
Q4 2023 Jan 25, 2024	BUY	$525.19 - $619.13 $106,088 - $125,064	202 Added 0.88%	23,270 $13.6 Million
Q3 2023 Oct 23, 2023	SELL	$434.7 - $599.3 $190,398 - $262,493	-438 Reduced 1.86%	23,068 $12.4 Million
Q2 2023 Jul 21, 2023	BUY	$350.74 - $468.98 $41,738 - $55,808	119 Added 0.51%	23,506 $11 Million
Q1 2023 Apr 25, 2023	SELL	$310.63 - $364.82 $310 - $364	-1 Reduced -0.0%	23,387 $8.03 Million
Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $22,830 - $26,601	-71 Reduced 0.3%	23,388 $0
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $5,040 - $5,743	-17 Reduced 0.07%	23,459 $7.59 Million
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $335,312 - $393,705	-1,203 Reduced 4.87%	23,476 $7.61 Million
Q4 2021 Jan 25, 2022	SELL	$224.85 - $279.04 $545,261 - $676,672	-2,425 Reduced 8.95%	24,679 $6.82 Million
Q3 2021 Oct 29, 2021	BUY	$221.6 - $272.71 $711,336 - $875,399	3,210 Added 13.43%	27,104 $6.26 Million
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $71,317 - $92,248	395 Added 1.68%	23,894 $5.48 Million
Q1 2021 Apr 20, 2021	SELL	$164.32 - $212.72 $34,835 - $45,096	-212 Reduced 0.89%	23,499 $4.39 Million
Q4 2020 Jan 20, 2021	SELL	$130.46 - $172.63 $37,963 - $50,235	-291 Reduced 1.21%	23,711 $4 Million
Q3 2020 Oct 16, 2020	BUY	$146.22 - $169.13 $14,622 - $16,913	100 Added 0.42%	24,002 $3.55 Million
Q2 2020 Jul 21, 2020	SELL	$136.42 - $164.18 $13,096 - $15,761	-96 Reduced 0.4%	23,902 $3.92 Million
Q1 2020 Apr 17, 2020	SELL	$119.05 - $147.35 $222,742 - $275,691	-1,871 Reduced 7.23%	23,998 $3.33 Million
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $197,160 - $244,200	1,844 Added 7.68%	25,869 $3.4 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $23,280 - $25,322	218 Added 0.92%	24,025 $2.69 Million
Q1 2019 Apr 16, 2019	SELL	$111.31 - $131.02 $17,809 - $20,963	-160 Reduced 0.67%	23,807 $3.09 Million
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $1,270 - $1,423	12 Added 0.05%	23,967 $2.77 Million
Q2 2018 Jul 24, 2018	BUY	$75.7 - $86.88 $41,256 - $47,349	545 Added 2.33%	23,955 $2.04 Million
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $20,259 - $23,914	-273 Reduced 1.15%	23,410 $1.81 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $34,005 - $36,474	415 Added 1.78%	23,683 $2 Million
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $1.79 Million - $1.99 Million	23,268	23,268 $1.99 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Busey Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Busey Wealth Management with notifications on news.

Account

Busey Wealth Management Eli Lilly & CO Transaction History